Cubist Systematic Strategies’s DICE Therapeutics DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-59,557
Closed -$2.77M – 4201
2023
Q2
$2.77M Buy
+59,557
New +$2.06M 0.02% 1252
2022
Q2
– Sell
-5,035
Closed -$96K – 4678
2022
Q1
$96K Sell
5,035
-9,235
-65% -$165K ﹤0.01% 3261
2021
Q4
$361K Buy
+14,270
New +$418K ﹤0.01% 2669

Cubist Systematic Strategies's DICE Position: Q3 2023 in Review

Cubist Systematic Strategies sold out of DICE Therapeutics (DICE) in Q3 2023, closing a stake of 59,557 shares — an estimated $2.77M sold.

Cubist Systematic Strategies first reported a position in DICE in Q4 2021 and held it in 3 quarters. The position peaked at $2.77M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Cubist Systematic Strategies reported no remaining DICE Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 59,557 DICE Therapeutics shares in Q3 2023, an estimated $2.77M.
  • Cubist Systematic Strategies first reported a position in DICE Therapeutics in Q4 2021 and held it in 3 quarters.
  • Cubist Systematic Strategies's DICE Therapeutics position peaked at $2.77M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics as of Q3 2023.

Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.